Celldex Therapeutics Stock Forecast

Buy or Hold candidate since Jul 20, 2026 Gain 0.65%

The Celldex Therapeutics stock price gained 1.05% on the last trading day (Monday, 27th Jul 2026), rising from $35.28 to $35.65. During the last trading day the stock fluctuated 3.59% from a day low at $35.12 to a day high of $36.38. The price has been going up and down for this period, and there has been a -7.47% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 526 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $36.56 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 17.95% during the next 3 months and, with a 90% probability hold a price between $37.71 and $48.80 at the end of this 3-month period.

CLDX Signals & Forecast

The Celldex Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $35.36 and $34.84. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -10.72%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Celldex Therapeutics stock

Celldex Therapeutics finds support from accumulated volume at $35.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.26 between high and low, or 3.59%. For the last week, the stock has had daily average volatility of 4.72%.

Celldex Therapeutics is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: $33.57 (-5.85%) (This stock has medium daily movements and this gives medium risk. Low RSI14 is 22 which reduces the risk some. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (CLDX) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Celldex Therapeutics to open at $35.72, and during the day (based on 14 day Average True Range), to move between $34.86 and $36.44, which gives a possible trading interval of +/-$1.57 (+/-4.51%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 4.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $35.26 (1.09%) than the resistance at $37.21 (4.38%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Celldex Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Celldex Therapeutics stock to perform well in the short-term.

Current score: 1.321 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 28, 2026 - $35.72 ( 0.188%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk